SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-026887
Filing Date
2024-07-11
Accepted
2024-07-11 08:15:22
Documents
19
Period of Report
2024-07-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43891
2 ex10-1.htm EX-10.1 134273
3 ex99-1.htm EX-99.1 24090
4 ex99-1_001.jpg GRAPHIC 2366
5 ex99-1_002.jpg GRAPHIC 45435
6 ex99-1_003.jpg GRAPHIC 24676
7 ex99-1_004.jpg GRAPHIC 34842
  Complete submission text file 0001493152-24-026887.txt   555132

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE mgrx-20240709.xsd EX-101.SCH 3033
9 XBRL LABEL FILE mgrx-20240709_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE mgrx-20240709_pre.xml EX-101.PRE 22371
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3808
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

IRS No.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 241111077
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)